Luqmani Y. Mechanisms of drug resistance in cancer chemotherapy. Med Principles Pract. 2005;14(Suppl 1):35–48.
Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299–309.
Article PubMed PubMed Central CAS Google Scholar
Wang X, Zhang H, Chen X. Drug resistance and combating drug resistance in cancer. Cancer drug Resist. 2019;2(2):141.
PubMed PubMed Central Google Scholar
Perez-Tomas R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem. 2006;13(16):1859–76.
Article PubMed CAS Google Scholar
Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, et al. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genom. 2011;4:1–14.
Meng X, Bai X, Ke A, Li K, Lei Y, Ding S, Dai D. Long non-coding RNAs in Drug Resistance of Gastric Cancer: Complex mechanisms and potential clinical applications. Biomolecules. 2024;14(6):608.
Article PubMed PubMed Central CAS Google Scholar
Binkhathlan Z, Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Curr Cancer Drug Targets. 2013;13(3):326–46.
Article PubMed CAS Google Scholar
Neophytou CM, Trougakos IP, Erin N, Papageorgis P. Apoptosis deregulation and the development of cancer multi-drug resistance. Cancers. 2021;13(17):4363.
Article PubMed PubMed Central CAS Google Scholar
Groth-Pedersen L, Jäättelä M. Combating apoptosis and multidrug resistant cancers by targeting lysosomes. Cancer Lett. 2013;332(2):265–74.
Article PubMed CAS Google Scholar
Riquelme I, Letelier P, Riffo-Campos AL, Brebi P, Roa JC. Emerging role of miRNAs in the drug resistance of gastric cancer. Int J Mol Sci. 2016;17(3):424.
Article PubMed PubMed Central Google Scholar
Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 2016;370(1):153–64.
Article PubMed CAS Google Scholar
Pavlíková L, Šereš M, Breier A, Sulová Z. The roles of microRNAs in cancer multidrug resistance. Cancers. 2022;14(4):1090.
Article PubMed PubMed Central Google Scholar
Gulia S, Chandra P, Das A. The prognosis of Cancer depends on the interplay of Autophagy, apoptosis, and Anoikis within the Tumor Microenvironment. Cell Biochem Biophys. 2023;81(4):621–58.
Article PubMed CAS Google Scholar
Anelli L, Zagaria A, Specchia G, Musto P, Albano F. Dysregulation of miRNA in leukemia: exploiting miRNA expression profiles as biomarkers. Int J Mol Sci. 2021;22(13):7156.
Article PubMed PubMed Central CAS Google Scholar
Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, et al. miRNA expression patterns in chemoresistant breast cancer tissues. Biomed Pharmacother. 2014;68(8):935–42.
Article PubMed CAS Google Scholar
Geretto M, Pulliero A, Rosano C, Zhabayeva D, Bersimbaev R, Izzotti A. Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators. Am J cancer Res. 2017;7(6):1350.
PubMed PubMed Central CAS Google Scholar
Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11:1–24.
Zheng T, Wang J, Chen X, Liu L. Role of microRNA in anticancer drug resistance. Int J Cancer. 2010;126(1):2–10.
Article PubMed CAS Google Scholar
Ranasinghe R, Mathai ML, Zulli A. Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon. 2022;8(9).
An X, Sarmiento C, Tan T, Zhu H. Regulation of multidrug resistance by microRNAs in anti-cancer therapy. Acta Pharm Sinica B. 2017;7(1):38–51.
Gulyaeva LF, Kushlinskiy NE. Regulatory mechanisms of microRNA expression. J Translational Med. 2016;14(1):143.
Wang S, Li M-Y, Liu Y, Vlantis AC, Chan JY, Xue L, et al. The role of microRNA in cisplatin resistance or sensitivity. Expert Opin Ther Targets. 2020;24(9):885–97.
Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93–110.
Chen Y, McCarthy D, Ritchie M, Robinson M, Smyth G, Hall E. edgeR: differential analysis of sequence read count data user’s guide. R Packag. 2020(June):1–121.
Law CW, Alhamdoosh M, Su S, Dong X, Tian L, Smyth GK, et al. RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR. F1000Research. 2016;5. Version 3.
Fattahi Dolatabadi N, Dehghani A, Shahand E, Yazdanshenas M, Tabatabaeian H, Zamani A, et al. The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer. Hum Cell. 2020;33(4):1229–39.
Article PubMed CAS Google Scholar
Kumar P, Nagarajan A, Uchil P. Analysis of cell viability by the MTT assay. Cold Spring Harbor Protoc. 2018;2018(6):pdbprot095505.
Barber RD, Harmer DW, Coleman RA, Clark BJ. GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genom. 2005;21(3):389–95.
Jafari N, Najafabadi AN, Hamzei B, Ataee N, Ghasemi Z, Sadeghian-Rizi T, et al. ESRG, LINC00518 and PWRN1 are newly-identified deregulated lncRNAs in colorectal cancer. Exp Mol Pathol. 2022;124:104732.
Article PubMed CAS Google Scholar
Motulsky H. Prism 5 statistics guide, 2007. GraphPad Software. 2007;31(1):39–42.
Zhou H, Feng B, Abudoureyimu M, Lai Y, Lin X, Tian C, et al. The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer. Life Sci. 2020;261:118362.
Article PubMed CAS Google Scholar
Barbato S, Solaini G, Fabbri M. MicroRNAs in oncogenesis and tumor suppression. Int Rev cell Mol Biology. 2017;333:229–68.
Otmani K, Lewalle P. Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol. 2021;11:708765.
Article PubMed PubMed Central CAS Google Scholar
Yang W, Ma J, Zhou W, Cao B, Zhou X, Yang Z, et al. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opin Ther Targets. 2017;21(11):1063–75.
Article PubMed CAS Google Scholar
Fuller RN, Vallejos PA, Kabagwira J, Liu T, Wang C, Wall NR. miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GR. Front Genet. 2024;15:1393353.
Article PubMed PubMed Central Google Scholar
Zhang J, Ma D, Kang H, Zhao J, Yang M. Long noncoding RNA LINC01287 promotes proliferation and inhibits apoptosis of lung adenocarcinoma cells via the miR-3529‐5p/RNASEH2A axis under the competitive endogenous RNA pattern. Environ Toxicol. 2021;36(10):2093–104.
Article PubMed CAS Google Scholar
Weng Z, Peng J, Wu W, Zhang C, Zhao J, Gao H. Downregulation of PART1 inhibits proliferation and differentiation of Hep3B cells by Targeting hsa-miR‐3529‐3p/FOXC2 Axis. J Oncol. 2021;2021(1):7792223.
留言 (0)